Paralos Bioscience
PrivateLast Round
Seed
Aug 27, 2026
Total Funding Raised
$566,484
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Paralos Bioscience operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in August 2026.
Paralos Bioscience is a biotechnology company developing a phage-drug conjugate platform for targeted therapeutic payload delivery to combat drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paralos Bioscience Comparables
Compare Paralos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhalconBio GmbH | 80% | |
| Obulytix | 77% | |
| Locus Biosciences | 76% |
For institutional investors. Book with your work email.
Paralos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 27, 2026 | ||||
| Accelerator | May 28, 2025 |
For institutional investors. Book with your work email.
Paralos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Seed, Accelerator |
| Carbon Silicon Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 189% MoM.
- Aug 27, 2026
Seed round raised with participation from Carbon Silicon Ventures, INCATE, and Larta Institute.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 10, 2026
Paralos Bioscience Inc. is developing a preclinical platform that uses phage targeting modules and drug payloads to direct treatments toward chosen targets, including drug-resistant infections.
For institutional investors. Book with your work email.
Paralos Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Paralos Bioscience's valuation, stock price, and market status.
Is Paralos Bioscience a public or private company?
Paralos Bioscience is a private company.
What is the current stock price of Paralos Bioscience?
Paralos Bioscience is a private company, so its shares have no public market price. Caplight tracks Paralos Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Paralos Bioscience worth (valuation)?
Valuation information for Paralos Bioscience is not publicly available.
Can I buy Paralos Bioscience stock?
Paralos Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Paralos Bioscience's last funding round?
Paralos Bioscience's most recent funding round was Seed on August 27, 2026.
Who are the main investors in Paralos Bioscience?
Key investors in Paralos Bioscience include INCATE, Carbon Silicon Ventures, National Institutes of Health (NIH).
Will Paralos Bioscience IPO soon?
No public IPO plans have been announced for Paralos Bioscience.
How can I track Paralos Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Paralos Bioscience's shares on secondary markets.